gip/glp-1 drugs Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP)

Additional information L-Carnitine 330mg, Excipient: Microcrystalline Cellulose (205mg), Disintegrating Agent: Calcium Carboxymethyl Cellulose (19mg), Bonding Agent: Povidone (18mg), Lubricant: Light Anhydrous Silicic Acid (15mg), Coating Agent: Opadry AMB II White (88A180040) (24mg), Coating Agent: Hypromellose (9mg), Coating Agent: Polyethylene Glycol 6000 (3.5mg), Light-Blocking Agent: Titanium Oxide (3.3mg)

This can look like insomnia, because you wake up over and over without remembering it

Nephrotoxicity of hemoglobin solutions

The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds

Ruth et al., 2021)

Consent for publication We confirm that the manuscript has been read and approved by all named authors, and that there are no other persons who satisfied the criteria for authorship but are not listed